BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Koufakis T, Patoulias D, Zografou I, Papanas N, Popovic DS. Drawing lines in the sand: The growing threat of obesity in type 1 diabetes. World J Diabetes 2024; 15(5): 823-827 [PMID: PMC11099370 DOI: 10.4239/wjd.v15.i5.823]
URL: https://www.wjgnet.com/1948-9358/full/v15/i5/823.htm
Number Citing Articles
1
Maria A. Christou, Panagiota A. Christou, Daphne N. Katsarou, Eleni I. Georga, Christos Kyriakopoulos, Georgios Markozannes, Georgios A. Christou, Dimitrios I. Fotiadis, Stelios Tigas. Effect of Body Weight on Glycaemic Indices in People with Type 1 Diabetes Using Continuous Glucose MonitoringJournal of Clinical Medicine 2024; 13(17): 5303 doi: 10.3390/jcm13175303
2
Janet K. Snell-Bergeon, Gurleen Kaur, Drew Renner, Halis K. Akturk, Christie Beatson, Satish K. Garg. Effectiveness of Semaglutide and Tirzepatide in Overweight and Obese Adults with Type 1 DiabetesDiabetes Technology & Therapeutics 2025; 27(1): 1 doi: 10.1089/dia.2024.0328
3
Paschalis Karakasis, Theocharis Koufakis, Dimitrios Patoulias, Fotios Barkas, Aleksandra Klisic, Milena Mitrovic, Michael Doumas, Nikolaos Papanas, Djordje S. Popovic. Effects of glucagon‐like peptide‐1 receptor agonists on glycated haemoglobin and continuous glucose monitoring metrics as adjunctive therapy to insulin in adults with type 1 diabetes: A meta‐analysis of randomized controlled trialsDiabetes, Obesity and Metabolism 2024; 26(12): 6043 doi: 10.1111/dom.15979